CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,519,090
- in 5 filings, $1.5M under 10b5-1 plans
Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-01 | Multani Pratik S Chief Medical Officer | Grant or award · Stock Option (right to buy) | +108,750 | 108,750 | ||
| 2022-02-01 | Multani Pratik S Chief Medical Officer | Grant or award · Restricted Stock Unit | +18,125 | 18,125 | ||
| 2022-02-01 | Piscitelli Dominic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +108,750 | 108,750 | ||
| 2022-02-01 | Piscitelli Dominic Chief Financial Officer | Grant or award · Restricted Stock Unit | +18,125 | 18,125 | ||
| 2022-02-01 | Chacko Jacob President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2022-02-01 | Chacko Jacob President and CEO | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2021-11-16 | COLUMN GROUP II, LP 10% owner | Other disposition | −1,200,000 | 3,568,181 | ||
| 2021-11-16 | COLUMN GROUP II, LP 10% owner | Other acquisition | +287,702 | 287,702 | ||
| 2021-11-16 | COLUMN GROUP II, LP 10% owner | Other disposition | −287,702 | 0 | ||
| 2021-11-16 | COLUMN GROUP II, LP 10% owner | Other acquisition | +86,716 | 86,716 | ||
| 2021-11-16 | COLUMN GROUP II, LP 10% owner | Other acquisition | +86,716 | 103,341 | ||
| 2021-11-16 | COLUMN GROUP II, LP 10% owner | Other acquisition | +74 | 74 | ||
| 2021-11-12 | COLUMN GROUP II, LP 10% owner | Option exercise | +16,625 | $16.00 | $266K | 16,625 |
| 2021-11-12 | COLUMN GROUP II, LP 10% owner | Option exercise · Stock Option (right to buy) | −16,625 | 0 | ||
| 2021-11-09 | You Angie Director | Grant or award · Stock Option (right to buy) | +33,250 | 33,250 | ||
| 2021-09-15 | Heyman Richard A. Director | Sale | −682 | $25.03 | $17K | 216,272 |
| 2021-09-15 | Chacko Jacob President and CEO | Sale | −3,736 | $25.06 | $94K | 2,652 |
| 2021-09-14 | Heyman Richard A. Director | Sale | −706 | $25.05 | $18K | 216,954 |
| 2021-09-14 | Chacko Jacob President and CEO | Sale | −4,420 | $25.05 | $111K | 6,388 |
| 2021-09-13 | Heyman Richard A. Director | Sale | −601 | $25.01 | $15K | 217,660 |
Page 11 of 12 · 228 trades